Lead Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Patients with non-segmental and segmental vitiligo under medical treatment at the Netherlands Institute for Pigment Disorders
•Age between 18 and 60 years
•Patient is willing and able to give written informed consent
•Vitiligo stable since 12 months without systemic therapy or 6 months without topical therapy as defined by the absence of new lesions and/or enlargement of existing lesions.
•Vitiligo lesions on the extremities or trunk larger than 5x5cm

•UV therapy or systemic immunosuppressive treatment during the last 12 months
•Local treatment of vitiligo during the last 6 months
•Vitiligo lesions with folliculair or non-folliculair repigmentations
•Skin type 1
•Hypertrophic scars
•Keloid
•Cardial insufficiency
•Patients with a history of hypersensitivity to (UVB) light and allergy to local anesthesia.
•Patients who are pregnant or breast-feeding
•Patients not competent to understand what the procedures involved
•Patients with a personal history of melanoma or non-melanoma skin cancer
•Patients with a first degree relative with melanoma skin cancer
•Patients with atypical nevi.

Related studies

NCT07431177 · Non-segmental Vitiligo

NCT07437560 · NonSegmental Vitiligo, Nonsegmental Vitiligo (Stable)

NCT06991972 · Vitiligo, Non-segmental Vitiligo

NCT06511739 · Non-segmental Vitiligo

NCT06113471 · NonSegmental Vitiligo

Punchgrafting Techniques for Vitiligo